Preventing subacute stent thrombosis--is there a role for heparin-coated stents?
Carrozza
Joseph P
JP
Chief, Section of Interventional Cardiology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA. jcarrozz@bidmc.harvard.edu
D000208:Acute Disease; D020099:Coated Materials, Biocompatible / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications / Q000628:therapy; D003328:Coronary Thrombosis / Q000209:etiology / Q000517:prevention & control*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D015607:Stents
D020099:Coated Materials, Biocompatible; D005343:Fibrinolytic Agents; D006493:Heparin